dr. catenacci on the challenges of developing novel therapies in gastroesophageal cancer
Published 4 years ago • 114 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:38
dr. catenacci on results of margetuximab plus pembrolizumab in gastric/gej cancer
-
10:00
novel agents for gastroesophageal cancer
-
6:14
novel targeted approaches in gastroesophageal cancer
-
1:08:22
statistical considerations in the clinical development of novel cancer therapies
-
3:11
daniel catenacci, md, discusses margetuximab in the treatment of esophageal and gastric cancer
-
1:25
dr. davis on caveats of the keynote-062 trial findings in gastric/gej cancer
-
2:42
overcoming the challenges faced in identifying novel targets for adc development
-
2:10
daniel catenacci, md, shares opinion on the role of checkpoint inhibitors for gi malignancies
-
12:23
materia medica: platina and cancer cas.
-
14:44
the role of allosct in patients with hl who relapse after autosct and the impact of novel agents
-
8:46
today immunotherapy can cure even fourth stage cancer: dr dattatreyudu nori
-
3:54
challenges for the future of gynecologic cancers
-
5:32
clinical trial challenges in metastatic crpc
-
8:12
gastroesophageal cancer: emerging approaches
-
22:01
clinical trials: the why and how
-
17:28
oncology clinical trials: an emerging paradigm shift in trial design
-
1:36:15
conversations on cancer: clinical trial site selection: fact vs fiction
-
6:40
sequencing decisions in gastric cancers
-
1:38:03
clinical trials updates for gastric cancer patients
-
5:42
evolving global treatment landscape for gastric cancer
-
1:23
dr. chase on challenges facing gynecologic cancers
-
5:39
understanding prognoses of advanced gastric/gej cancers